The transcutaneous electrical nerve stimulation (TENS) market was valued at USD 408.68 million in 2026, expanding at a CAGR of 8.98% by 2035. This growth is supported by the rising need for non-invasive, opioid-free pain management and a shift toward self-managed and portable recovery solutions. The market analysis was conducted by Deepa Pandey, a healthcare research analyst at Precedence Research. Her research helps medical product manufacturers, healthcare providers, biotechnology companies, and investors with competitive benchmarking and strategic decision-making.